Showing results (21-30 of 154) with videos related to
Sort By:
Pageof 16
Leukemia Research|January 1, 2016
Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasmsAnders Lindholm Sørensen, Hans Carl HasselbalchMediators of Inflammation|November 26, 2015
MPNs as Inflammatory Diseases: The Evidence, Consequences, and PerspectivesHans Carl Hasselbalch, Mads Emil BjørnMediators of Inflammation|November 6, 2015
The Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsMads Emil Bjørn, Hans Carl HasselbalchLeukemia Research Reports|December 28, 2013
Myeloproliferative neoplasms in five multiple sclerosis patientsSigrun Thorsteinsdottir, Ole Weis Bjerrum, Hans Carl HasselbalchLeukemia Research Reports|August 5, 2016
A remarkable hematological and molecular response pattern in a patient with polycythemia vera during combination therapy with simvastatin and alendronateAnders Lindholm Sørensen, Klaus Kallenbach, Hans Carl HasselbalchCancers|March 4, 2020
Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative NeoplasmsCharlotte Liisborg, Hans Carl Hasselbalch, Torben Lykke SørensenBlood|March 2, 2021
The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasmsHans Carl Hasselbalch, Margitta Elvers, Andrew I SchaferOncoimmunology|November 18, 2017
The <i>JAK2</i>V617F and <i>CALR</i> exon 9 mutations are shared immunogenic neoantigens in hematological malignancyMorten Orebo Holmström, Hans Carl Hasselbalch, Mads Hald AndersenAmerican Journal of Hematology|July 12, 2002
Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietinHans Carl Hasselbalch, Nielsaage Tøffner Clausen, Bjarne Anker JensenLeukemia & Lymphoma|February 17, 2016
Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?Mette Vestergaard Elbæk, Anders Lindholm Sørensen, Hans Carl HasselbalchPageof 16